Recent funding opportunities and notices
This alert links to all of the Funding Opportunity Announcements and Notices published by the National Institute on Aging at NIH in the previous month, giving researchers and trainees a heads up about what’s new.
Read about the latest NIA Funding Opportunities (published in June 2022) by clicking on the links below:
- RFA-AG-23-022: Measures and Methods for Research on Family Caregivers for People Living with Alzheimer’s Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Not Allowed)
- RFA-AG-23-023: Measures and Methods for Research on Family Caregivers for People Living with Alzheimer’s Disease and Related Dementias (AD/ADRD) (R21 Clinical Trial Not Allowed)
- RFA-AG-23-032: Network for Personalization of Diagnostic Tests for Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD) in Older Adults with Multiple Chronic Conditions (MCCs) (U24 Clinical Trial Optional)
- RFA-AG-23-033: Transformative Artificial Intelligence and Machine Learning Based Strategies to Identify Determinants of Exceptional Health and Life Span (R21/R33 Clinical Trial Not Allowed)
- PAS-22-196: Advancing Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)
- PAS-22-197: Advancing Research on Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Notices
- NOT-AG-22-022: Notice of Special Interest (NOSI): Administrative Supplements to Support Research Infrastructure on Exposome Studies in Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD)
- NOT-AG-22-023: Notice of Intent to Publish Funding Opportunity Announcements for Resource Centers for Minority Aging Research (RCMARs) and AD/ADRD RCMARs (P30 Clinical Trial Optional)
- NOT-AG-22-024: Notice of Intent to Publish a Funding Opportunity Announcement for Resource Centers for Minority Aging Research (RCMAR) Coordinating Center (U24 Clinical Trial Optional)
- NOT-AG-22-026: Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed)
Last Updated on July 21, 2022
